Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C046782 |
14,15-epoxy-5,8,11-eicosatrienoic acid |
14,15-epoxy-5,8,11-eicosatrienoic acid results in increased expression of FGF2 protein | increases expression | 16286479
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased expression of and results in increased activity of HIF1A protein] | decreases reaction|increases activity|increases expression | 15631803
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15631803
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 16303940
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased stability of and results in increased expression of COL1A1 protein] | decreases reaction|increases expression|increases stability | 16303940
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased stability of and results in increased expression of COL1A2 protein] | decreases reaction|increases expression|increases stability | 16303940
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[FGF2 protein binds to and results in increased activity of FGFR4 protein] which results in increased phosphorylation of MAPK1 protein] | affects binding|decreases reaction|increases activity|increases phosphorylation | 11336793
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of FGF2 mRNA | increases expression | 20406850
|
C082182 |
3,5-diiodothyropropionic acid |
3,5-diiodothyropropionic acid results in increased expression of FGF2 protein | increases expression | 16384862
|
C075773 |
4-phenylbutyric acid |
4-phenylbutyric acid results in decreased expression of FGF2 mRNA | decreases expression | 14583596
|
D000111 |
Acetylcysteine |
Acetylcysteine results in decreased expression of FGF2 mRNA | decreases expression | 16084531
|
D000117 |
Acetylglucosamine |
Acetylglucosamine analog promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 12440867
|
D020106 |
Acrylamide |
Acrylamide analog promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 12440867
|
D020106 |
Acrylamide |
Acrylamide analog inhibits the reaction [Trifluoroacetic Acid results in increased degradation of FGF2 protein] | decreases reaction|increases degradation | 14733594
|
D020106 |
Acrylamide |
Acrylamide analog promotes the reaction [FGF2 protein binds to FGF2 protein] | affects binding|increases reaction | 14733594
|
C006453 |
alliin |
alliin results in decreased activity of FGF2 protein | decreases activity | 16351512
|
C006453 |
alliin |
Ascorbic Acid promotes the reaction [alliin results in decreased activity of FGF2 protein] | decreases activity|increases reaction | 16351512
|
C006453 |
alliin |
Vitamin E promotes the reaction [alliin results in decreased activity of FGF2 protein] | decreases activity|increases reaction | 16351512
|
C006453 |
alliin |
alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein] | increases expression|increases reaction | 16351512
|
C006453 |
alliin |
alliin results in decreased secretion of FGF2 protein | decreases secretion | 16351512
|
D000538 |
Aluminum Silicates |
Aluminum Silicates results in increased secretion of FGF2 protein | increases secretion | 16335828
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FGF2 mRNA | affects expression | 16483693
|
D000661 |
Amphetamine |
Amphetamine results in increased expression of FGF2 protein | increases expression | 16338078
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [IL1A protein results in increased expression of FGF2 mRNA] | decreases reaction|increases expression | 12832416
|
D001149 |
Arsenates |
Arsenates results in increased expression of FGF2 mRNA | increases expression | 15345372
|
C015001 |
arsenite |
arsenite results in increased expression of FGF2 mRNA | increases expression | 15345372
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of FGF2 mRNA | affects expression | 17331233
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of FGF2 mRNA | increases expression | 18687144
|
D001205 |
Ascorbic Acid |
Ascorbic Acid promotes the reaction [alliin results in decreased activity of FGF2 protein] | decreases activity|increases reaction | 16351512
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of FGF2 mRNA | increases expression | 19181443
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] | decreases reaction|increases expression | 12403780
|
D002101 |
Cacodylic Acid |
Cacodylic Acid results in increased expression of FGF2 mRNA | increases expression | 15345372
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [FGF2 protein results in increased expression of and results in increased activity of RUNX2 protein] | decreases reaction|increases activity|increases expression | 12403780
|
C058819 |
calphostin C |
calphostin C inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] | decreases reaction|increases expression | 12403780
|
D002251 |
Carbon Tetrachloride |
FGF2 protein affects the susceptibility to Carbon Tetrachloride | affects response to substance | 14507672
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of FGF2 mRNA | increases expression | 17158861
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of FGF2 protein | increases expression | 16116963
|
D002713 |
Chlorine |
Chlorine results in decreased expression of FGF2 mRNA | decreases expression | 18636392
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] affects the expression of FGF2 mRNA | affects cotreatment|affects expression | 18636392
|
D004390 |
Chlorpyrifos |
Chlorpyrifos results in decreased expression of FGF2 mRNA | decreases expression | 17589599
|
D002809 |
Chondroitin Sulfates |
Chondroitin Sulfates analog binds to FGF2 protein | affects binding | 12221095
|
D002809 |
Chondroitin Sulfates |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein | affects binding | 15385557
|
D002809 |
Chondroitin Sulfates |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein | affects binding | 14699094
|
C065927 |
cilnidipine |
cilnidipine results in decreased expression of FGF2 mRNA | decreases expression | 16333380
|
D003008 |
Cloprostenol |
Cloprostenol results in increased expression of FGF2 mRNA | increases expression | 14991729
|
D003024 |
Clozapine |
Clozapine results in increased expression of FGF2 mRNA | increases expression | 11264663
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Dinoprost affects the localization of FGF2 protein] | affects localization|decreases reaction | 15654655
|
D003871 |
Dermatan Sulfate |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein | affects binding | 15385557
|
D003871 |
Dermatan Sulfate |
Dermatan Sulfate analog results in increased activity of FGF2 protein | increases activity | 15563459
|
D003871 |
Dermatan Sulfate |
[Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein | affects binding | 14699094
|
D003907 |
Dexamethasone |
Dexamethasone inhibits the reaction [nitrofen results in decreased expression of FGF2 mRNA] | decreases expression|decreases reaction | 10646786
|
D003976 |
Diazinon |
Diazinon results in decreased expression of FGF2 mRNA | decreases expression | 19130878 17589599
|
D004026 |
Dieldrin |
Dieldrin results in decreased expression of FGF2 mRNA | decreases expression | 19130878
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of FGF2 mRNA | decreases expression | 17005392
|
D004280 |
Dobutamine |
FGF2 protein affects the susceptibility to Dobutamine | affects response to substance | 14583313
|
D004280 |
Dobutamine |
FGF2 protein affects the susceptibility to Dobutamine | affects response to substance | 10491406
|
D004365 |
Drugs, Chinese Herbal |
Drugs, Chinese Herbal results in increased expression of FGF2 mRNA | increases expression | 16313111
|
C117757 |
E 5842 |
E 5842 results in decreased expression of FGF2 mRNA | decreases expression | 11264663
|
C117757 |
E 5842 |
E 5842 results in increased expression of FGF2 mRNA | increases expression | 11264663
|
C117757 |
E 5842 |
E 5842 results in increased expression of FGF2 protein | increases expression | 11264663
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of FGF2 mRNA | decreases expression | 16084531
|
D004958 |
Estradiol |
Estradiol results in increased expression of FGF2 mRNA | increases expression | 15367264
|
D004958 |
Estradiol |
Estradiol results in increased expression of FGF2 mRNA | increases expression | 21098263
|
C024552 |
estrone benzoate |
estrone benzoate results in decreased expression of FGF2 mRNA | decreases expression | 15120423
|
C024552 |
estrone benzoate |
Progesterone inhibits the reaction [estrone benzoate results in decreased expression of FGF2 mRNA] | decreases expression|decreases reaction | 15120423
|
D005047 |
Etoposide |
FGF2 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of FGF2 mRNA | decreases expression | 16510598
|
D005576 |
Forskolin |
Forskolin results in increased expression of FGF2 mRNA | increases expression | 10320526
|
D005576 |
Forskolin |
Forskolin results in increased expression of FGF2 protein | increases expression | 10320526
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein] | decreases reaction|increases expression | 20179196
|
D005665 |
Furosemide |
Furosemide results in decreased expression of FGF2 mRNA | decreases expression | 16526316
|
D019833 |
Genistein |
Genistein results in decreased activity of FGF2 protein | decreases activity | 10569980
|
D006025 |
Glycosaminoglycans |
Glycosaminoglycans results in increased activity of FGF2 protein | increases activity | 12659634
|
D006072 |
Gossypol |
Gossypol results in decreased expression of FGF2 mRNA | decreases expression | 19825521
|
D006072 |
Gossypol |
zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGF2 mRNA] | decreases expression|increases reaction | 19825521
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGF2 protein] | affects localization|decreases reaction | 15654655
|
D019812 |
Heparan Sulfate Proteoglycans |
[Heparan Sulfate Proteoglycans binds to and results in increased activity of FGF2 protein] which results in increased expression of TNFSF11 protein | affects binding|increases activity|increases expression | 15334457
|
D019812 |
Heparan Sulfate Proteoglycans |
[Heparan Sulfate Proteoglycans binds to FGF2 protein binds to FGFR1 protein] which binds to KAL1 protein | affects binding | 15548653
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans affects the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|affects reaction | 10336501
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans affects the reaction [FGF2 protein binds to FGFR4 protein] | affects binding|affects reaction | 10336501
|
D019812 |
Heparan Sulfate Proteoglycans |
Heparan Sulfate Proteoglycans binds to FGF2 protein | affects binding | 8227197
|
D006493 |
Heparin |
Heparin promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 12440867
|
D006493 |
Heparin |
Heparin results in decreased activity of FGF2 protein | decreases activity | 10569980 15051888
|
D006493 |
Heparin |
Heparin binds to FGFR1 protein binds to FGF2 protein | affects binding | 15096041
|
D006493 |
Heparin |
Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] | affects binding|increases reaction | 1379594
|
D006493 |
Heparin |
Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] | affects binding|increases reaction | 1373495
|
D006493 |
Heparin |
Heparin affects the activity of FGF2 protein | affects activity | 15232299
|
D006493 |
Heparin |
Heparin affects the reaction [FGF2 protein binds to FGFR4 protein] | affects binding|affects reaction | 10336501
|
D006493 |
Heparin |
[Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein | affects binding | 10860838
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K1 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAP2K2 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006493 |
Heparin |
Heparin inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 14966081
|
D006493 |
Heparin |
Heparin analog binds to and results in decreased degradation of FGF2 protein | affects binding|decreases degradation | 9174673
|
D006493 |
Heparin |
Heparin binds to FGF2 protein | affects binding | 7547864 15632177
|
D006493 |
Heparin |
Heparin promotes the reaction [FGF2 protein results in increased activity of FGFR1 protein] | increases activity|increases reaction | 12799194
|
D006493 |
Heparin |
Heparin results in increased activity of FGF2 protein | increases activity | 12799194
|
D006493 |
Heparin |
phosphomannopentaose sulfate inhibits the reaction [Heparin binds to FGF2 protein] | affects binding|decreases reaction | 15632177
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate binds to and affects the activity of FGF2 protein | affects activity|affects binding | 15958608
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate analog results in increased activity of FGF2 protein | increases activity | 12460940
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate binds to FGF2 protein | affects binding | 15464572
|
D006497 |
Heparitin Sulfate |
Heparitin Sulfate analog binds to FGF2 protein | affects binding | 14707131 15081013
|
D006583 |
Hexadimethrine |
Hexadimethrine results in decreased activity of FGF2 protein | decreases activity | 10569980
|
C482862 |
heyneanol A |
heyneanol A results in decreased activity of FGF2 protein | decreases activity | 16675471
|
D006851 |
Hydrochloric Acid |
Hydrochloric Acid results in decreased expression of FGF2 mRNA | decreases expression | 15046208
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide promotes the reaction [FGF2 protein binds to FGFR1 protein] | affects binding|increases reaction | 8849686
|
D016285 |
Iloprost |
Iloprost results in increased expression of FGF2 mRNA | increases expression | 16373414
|
D016285 |
Iloprost |
tyrphostin AG 1478 inhibits the reaction [Iloprost results in increased expression of FGF2 mRNA] | decreases reaction|increases expression | 16373414
|
C056493 |
imiquimod |
imiquimod results in decreased expression of FGF2 | decreases expression | 16368197
|
C056493 |
imiquimod |
imiquimod results in decreased expression of FGF2 | decreases expression | 16302556
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein] | decreases reaction|increases expression | 11170841
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [FGF2 protein results in increased expression of CCNE1 protein] | decreases reaction|increases expression | 11170841
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [FGF2 protein results in increased phosphorylation of RB1 protein] | decreases reaction|increases phosphorylation | 11170841
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of FGF2 mRNA | increases expression | 17440234
|
C051890 |
irinotecan |
irinotecan metabolite results in increased expression of FGF2 mRNA | increases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in increased expression of FGF2 mRNA | increases expression | 15956246
|
D007608 |
Kainic Acid |
Kainic Acid results in increased expression of FGF2 mRNA | increases expression | 7649223
|
D008628 |
Mercury |
Mercury results in increased expression of FGF2 mRNA | increases expression | 16823088
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of FGF2 mRNA | decreases expression | 12517777
|
C020300 |
monomethylarsonic acid |
monomethylarsonic acid results in increased expression of FGF2 mRNA | increases expression | 15345372
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased expression of BDNF mRNA] | decreases reaction|increases expression | 16269011
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased expression of NTRK2 mRNA] | decreases reaction|increases expression | 16269011
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased phosphorylation of CREB1 protein] | decreases reaction|increases phosphorylation | 16269011
|
C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269011
|
D009532 |
Nickel |
Nickel results in decreased expression of FGF2 mRNA | decreases expression | 19130878
|
D009538 |
Nicotine |
Nicotine results in increased secretion of FGF2 protein | increases secretion | 16365874
|
D009538 |
Nicotine |
Nicotine results in decreased expression of FGF2 protein | decreases expression | 14732461
|
D009538 |
Nicotine |
Nicotine results in increased expression of FGF2 mRNA | increases expression | 15465631
|
D009538 |
Nicotine |
Nicotine results in increased expression of FGF2 protein | increases expression | 15465631
|
D009543 |
Nifedipine |
Nifedipine inhibits the reaction [FGF2 protein results in increased expression of FOS mRNA] | decreases reaction|increases expression | 16188231
|
C007350 |
nitrofen |
Dexamethasone inhibits the reaction [nitrofen results in decreased expression of FGF2 mRNA] | decreases expression|decreases reaction | 10646786
|
C007350 |
nitrofen |
nitrofen results in decreased expression of FGF2 mRNA | decreases expression | 10646786 10898222
|
D026423 |
S-Nitroso-N-Acetylpenicillamine |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] | increases expression|increases reaction | 16351512
|
D009844 |
Oligosaccharides |
Oligosaccharides binds to and results in decreased degradation of FGF2 protein | affects binding|decreases degradation | 9174673
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] affects the expression of FGF2 mRNA | affects cotreatment|affects expression | 18636392
|
C002669 |
parthenolide |
parthenolide inhibits the reaction [FGF2 protein results in increased activity of [NFKB1 protein binds to RELA protein]] | affects binding|decreases reaction|increases activity | 16921510
|
C002669 |
parthenolide |
parthenolide inhibits the reaction [FGF2 protein results in increased expression of TRAF1 mRNA] | decreases reaction|increases expression | 16921510
|
C002669 |
parthenolide |
parthenolide inhibits the reaction [FGF2 protein results in increased expression of TRAF2 mRNA] | decreases reaction|increases expression | 16921510
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased activity of HIF1A protein] | decreases reaction|increases activity | 15631803
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15631803
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 15631803
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased expression of PLAU mRNA] | decreases reaction|increases expression | 9442043
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased expression of BDNF mRNA] | decreases reaction|increases expression | 16269011
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased phosphorylation of CREB1 protein] | decreases reaction|increases phosphorylation | 16269011
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 16269011
|
D010656 |
Phenylephrine |
Phenylephrine promotes the reaction [EGR1 protein binds to FGF2 promoter] | affects binding|increases reaction | 10779383
|
C120158 |
phosphomannopentaose sulfate |
phosphomannopentaose sulfate analog binds to FGF2 protein | affects binding | 16366604
|
C120158 |
phosphomannopentaose sulfate |
phosphomannopentaose sulfate binds to FGF2 protein | affects binding | 16366604
|
C120158 |
phosphomannopentaose sulfate |
phosphomannopentaose sulfate inhibits the reaction [Heparin binds to FGF2 protein] | affects binding|decreases reaction | 15632177
|
C025299 |
polyphenols |
polyphenols results in decreased expression of FGF2 mRNA | decreases expression | 16293270
|
D011374 |
Progesterone |
Progesterone inhibits the reaction [estrone benzoate results in decreased expression of FGF2 mRNA] | decreases expression|decreases reaction | 15120423
|
D015237 |
Dinoprost |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGF2 protein] | affects localization|decreases reaction | 15654655
|
D015237 |
Dinoprost |
Cycloheximide inhibits the reaction [Dinoprost affects the localization of FGF2 protein] | affects localization|decreases reaction | 15654655
|
D015237 |
Dinoprost |
Dinoprost affects the localization of FGF2 protein | affects localization | 15654655
|
D015237 |
Dinoprost |
Dinoprost affects the localization of [FGF2 protein binds to FGFR2 protein] | affects binding|affects localization | 16365892
|
D015237 |
Dinoprost |
Dinoprost promotes the reaction [FGF2 protein binds to FGFR2 protein] | affects binding|increases reaction | 16365892
|
D015237 |
Dinoprost |
Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGF2 protein] | affects localization|decreases reaction | 15654655
|
C059514 |
resveratrol |
resveratrol results in decreased expression of FGF2 mRNA | decreases expression | 17935668
|
C059514 |
resveratrol |
resveratrol results in decreased expression of FGF2 protein | decreases expression | 17935668
|
C059514 |
resveratrol |
resveratrol results in decreased activity of FGF2 protein | decreases activity | 16675471
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [FGF2 protein results in increased activity of RUNX2 protein] | decreases reaction|increases activity | 12403780
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] | decreases reaction|increases expression | 12403780
|
C079198 |
S 1 (combination) |
S 1 (combination) results in decreased expression of FGF2 mRNA | decreases expression | 18607998
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK14 protein] | decreases reaction|increases phosphorylation | 15631803
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [FGF2 protein results in increased phosphorylation of RB1 protein] | decreases reaction|increases phosphorylation | 15249425
|
C093642 |
SB 203580 |
SB 203580 results in decreased activity of FGF2 protein | decreases activity | 15249425
|
C484876 |
scutellarin |
scutellarin results in decreased expression of FGF2 protein | decreases expression | 16297343
|
C440975 |
silybin |
silybin inhibits the reaction [Urethane results in increased secretion of FGF2 protein] | decreases reaction|increases secretion | 16788158
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of FGF2 mRNA | decreases expression | 19615344
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of FGF2 mRNA | increases expression | 12703962
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased expression of and results in increased activity of HIF1A protein] | decreases reaction|increases activity|increases expression | 15631803
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased expression of FOS mRNA] | decreases reaction|increases expression | 16188231
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased expression of TACR1 mRNA alternative form] | decreases reaction|increases expression | 16154193
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 15631803
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK14 protein] | decreases reaction|increases phosphorylation | 15631803
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 15631803
|
C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 15631803
|
C105686 |
SU 5402 |
SU 5402 results in decreased expression of FGF2 mRNA | decreases expression | 12421715
|
C105686 |
SU 5402 |
SU 5402 results in increased expression of FGF2 mRNA | increases expression | 12421715
|
C105686 |
SU 5402 |
SU 5402 results in decreased activity of FGF2 protein | decreases activity | 12076337
|
D013498 |
Suramin |
Suramin results in increased expression of FGF2 | increases expression | 8394679
|
D014284 |
Triiodothyronine |
Triiodothyronine inhibits the reaction [FGF2 protein results in increased phosphorylation of STAT1 protein] | decreases reaction|increases phosphorylation | 16150908
|
D014284 |
Triiodothyronine |
Triiodothyronine promotes the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] | increases phosphorylation|increases reaction | 16150908
|
D014284 |
Triiodothyronine |
Triiodothyronine promotes the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] | increases phosphorylation|increases reaction | 16150908
|
D014284 |
Triiodothyronine |
Triiodothyronine promotes the reaction [FGF2 protein promotes the reaction [FGFR1 protein results in increased phosphorylation of FGFR1 protein]] | increases phosphorylation|increases reaction | 12805413
|
D014284 |
Triiodothyronine |
Triiodothyronine promotes the reaction [FGF2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] | increases activity|increases phosphorylation|increases reaction | 12805413
|
D014284 |
Triiodothyronine |
Triiodothyronine promotes the reaction [FGF2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] | increases activity|increases phosphorylation|increases reaction | 12805413
|
D013629 |
Tamoxifen |
FGF2 protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 20179196
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein] | decreases reaction|increases expression | 20179196
|
C047246 |
temozolomide |
[temozolomide co-treated with Thalidomide] results in decreased expression of FGF2 protein | affects cotreatment|decreases expression | 16327979
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FGF2 mRNA | increases expression | 12377990
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of FGF2 mRNA | affects expression | 12167310
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased secretion of FGF2 protein | increases secretion | 11874475
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGF2 protein] | affects localization|decreases reaction | 15654655
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate promotes the reaction [EGR1 protein binds to FGF2 promoter] | affects binding|increases reaction | 10779383
|
D013792 |
Thalidomide |
Thalidomide affects the expression of FGF2 mRNA | affects expression | 15939924
|
D013792 |
Thalidomide |
Thalidomide affects the expression of FGF2 protein | affects expression | 15939924
|
D013792 |
Thalidomide |
Thalidomide affects the secretion of FGF2 protein | affects secretion | 15939924
|
D013792 |
Thalidomide |
[temozolomide co-treated with Thalidomide] results in decreased expression of FGF2 protein | affects cotreatment|decreases expression | 16327979
|
D024505 |
Tocopherols |
Tocopherols results in decreased expression of FGF2 mRNA | decreases expression | 15878867
|
D019772 |
Topotecan |
FGF2 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014107 |
Tosyllysine Chloromethyl Ketone |
Tosyllysine Chloromethyl Ketone inhibits the reaction [FGF2 protein results in increased expression of NRP1 mRNA] | decreases reaction|increases expression | 16289960
|
D014212 |
Tretinoin |
FGF2 protein promotes the reaction [Tretinoin results in increased expression of GAB2 protein] | increases expression|increases reaction | 16009726
|
D014212 |
Tretinoin |
FGF2 protein promotes the reaction [Tretinoin results in increased expression of TUBB3 protein] | increases expression|increases reaction | 16009726
|
D014212 |
Tretinoin |
FGF2 protein results in decreased susceptibility to Tretinoin | decreases response to substance | 16009726
|
D014212 |
Tretinoin |
GAB2 protein promotes the reaction [FGF2 protein results in decreased susceptibility to Tretinoin] | decreases response to substance|increases reaction | 16009726
|
D014269 |
Trifluoroacetic Acid |
Acrylamide analog inhibits the reaction [Trifluoroacetic Acid results in increased degradation of FGF2 protein] | decreases reaction|increases degradation | 14733594
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [Iloprost results in increased expression of FGF2 mRNA] | decreases reaction|increases expression | 16373414
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [FGF2 protein results in increased expression of NRP1 mRNA] | decreases reaction|increases expression | 16289960
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [FGF2 protein results in increased expression of BDNF mRNA] | decreases reaction|increases expression | 16269011
|
D014520 |
Urethane |
silybin inhibits the reaction [Urethane results in increased secretion of FGF2 protein] | decreases reaction|increases secretion | 16788158
|
D014520 |
Urethane |
Urethane results in increased secretion of FGF2 protein | increases secretion | 16788158
|
C066075 |
vanadium pentoxide |
vanadium pentoxide results in decreased expression of FGF2 mRNA | decreases expression | 17459161
|
D014810 |
Vitamin E |
Vitamin E promotes the reaction [alliin results in decreased activity of FGF2 protein] | decreases activity|increases reaction | 16351512
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [[FGF2 protein binds to and results in increased activity of FGFR4 protein] which results in increased phosphorylation of MAPK1 protein] | affects binding|decreases reaction|increases activity|increases phosphorylation | 11336793
|
C088658 |
zoledronic acid |
zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGF2 mRNA] | decreases expression|increases reaction | 19825521
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.63 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
5.79 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
5.79 | 8333272 |
MESH:D000038 |
Abscess |
|
Drugs, Chinese Herbal |
5.40 | 15043669 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
7.77 | 18287403 |
MESH:D000138 |
Acidosis |
|
Hydrochloric Acid |
7.77 | 11574821 19262391 16144966 12771618 15920416 20872349 |
MESH:D000141 |
Acidosis, Renal Tubular |
|
Hydrochloric Acid |
4.89 | 17183249 |
MESH:D000142 |
Acidosis, Respiratory |
|
Hydrochloric Acid |
4.90 | 20597076 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.60 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
6.38 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
6.38 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
10.82 | 20601635 |
MESH:D055371 |
Acute Lung Injury |
|
Hydrochloric Acid |
10.82 | 11850527 19094174 15970105 11953099 19760209 19060228 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
10.82 | 16166738 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
4.58 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.59 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
12.59 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
12.59 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
12.59 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
12.59 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
12.59 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
4.80 | 15814487 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.10 | 6695378 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
11.10 | 11497255 |
MESH:D000236 |
Adenoma |
|
resveratrol |
11.10 | 15688382 |
MESH:D000236 |
Adenoma |
|
Urethane |
11.10 | 6695378 17195641 16926031 10530776 10822126 11497255 17093202 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
2.49 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.79 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
3.99 | 16712894 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.18 | 14617031 16160616 12649775 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
6.25 | 11874814 16611668 17119214 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
6.25 | 16487989 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
2.87 | 15955085 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.46 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
6.85 | 17627676 15579461 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
6.85 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
6.85 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
6.85 | 16162502 16183991 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.16 | 18475255 15010207 16459022 16916582 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.62 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
3.73 | 16510725 |
MESH:D000740 |
Anemia |
|
Drugs, Chinese Herbal |
10.34 | 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
10.34 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
10.34 | 11748828 |
MESH:D000787 |
Angina Pectoris |
|
Drugs, Chinese Herbal |
4.51 | 11477813 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
4.21 | 12005258 16101753 16084549 12183048 |
MESH:D000860 |
Anoxia |
|
Hydrochloric Acid |
4.41 | 15090967 |
MESH:D001004 |
Anus Diseases |
|
Drugs, Chinese Herbal |
5.05 | 15043669 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
3.99 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
8.80 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
8.80 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.32 | 17460149 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.26 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
12.44 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
12.44 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
12.44 | 9598899 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
12.44 | 16412693 |
MESH:D015210 |
Arthritis, Gouty |
|
Drugs, Chinese Herbal |
4.85 | 19655406 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
5.55 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
5.55 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
5.55 | 16292516 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
5.75 | 16516891 |
MESH:D001249 |
Asthma |
|
Ozone |
5.75 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.75 | 16456186 |
MESH:D001254 |
Astrocytoma |
|
temozolomide |
5.59 | 15865885 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
2.69 | 17967414 16873680 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
3.99 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.98 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
8.34 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
8.34 | 16634805 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.54 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.10 | 10684365 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Hydrochloric Acid |
10.79 | 15920416 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.79 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.79 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.88 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.12 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
4.25 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.12 | 19442620 15867366 11697798 17312309 16121404 16778634 |
MESH:D001862 |
Bone Resorption |
|
Drugs, Chinese Herbal |
7.44 | 9881647 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
7.44 | 18404659 8053405 16769263 18496637 15845617 11869084 |
MESH:D001913 |
Bowen's Disease |
|
imiquimod |
5.53 | 11207687 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
3.66 | 15306635 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
4.11 | 11481608 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.42 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.38 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
12.24 | 12524144 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
12.24 | 17600658 |
MESH:D002545 |
Brain Ischemia |
|
scutellarin |
12.24 | 16297343 |
MESH:D001943 |
Breast Neoplasms |
|
Acrylamide |
18.80 | 18183576 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
18.80 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
18.80 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
18.80 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
18.80 | 11859874 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
18.80 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
18.80 | 16675129 12948864 17261762 17289903 14630087 17018787 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
18.80 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
18.80 | 16110121 15136595 18357371 19217205 16557594 16595493 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
18.80 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
18.80 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
18.80 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
18.80 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
parthenolide |
18.80 | 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
18.80 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
18.80 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
18.80 | 19155303 21138602 18629630 19066611 19189210 17049068 20135344 20005174 18855134 20390343 20544844 16818667 19221464 20065188 11161223 17242785 18815881 21152245 17893378 19289846 15565566 19244106 16202921 18821012 19189212 17440819 19115204 19142967 18351453 18425577 19011961 19103187 19288272 19059307 20859285 17261762 15668708 19410462 19084267 19200415 18984771 16273361 16873071 18997820 19487384 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
18.80 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
18.80 | 16166294 16443354 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
18.80 | 18695136 16096432 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Hydrochloric Acid |
10.18 | 12378975 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
10.18 | 15516495 16777450 18315731 17626835 18417511 19059883 14754758 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
10.18 | 12794006 |
MESH:D001986 |
Bronchial Spasm |
|
Hydrochloric Acid |
4.56 | 15578804 |
MESH:D001991 |
Bronchitis |
|
vanadium pentoxide |
5.32 | 17459161 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.69 | 16813970 |
MESH:D002056 |
Burns |
|
Indomethacin |
3.83 | 10459503 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
9.43 | 15625704 16537180 11239499 15141370 |
MESH:D002100 |
Cachexia |
|
Ozone |
9.43 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.57 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
7.04 | 15721981 3786805 15673190 16011737 16227642 10355542 15700767 16192424 16124888 16050911 16097048 18705752 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
7.04 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
3.76 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
5.72 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
5.72 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
imiquimod |
4.58 | 16302556 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.63 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.24 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
25.48 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
25.48 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
25.48 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
25.48 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
25.48 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
25.48 | 16799960 16332177 17971768 17045692 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
25.48 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
25.48 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
25.48 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
25.48 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
25.48 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
25.48 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
25.48 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
heyneanol A |
14.19 | 16675471 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
14.19 | 11053908 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
14.19 | 16675471 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.45 | 14736730 11352223 18791128 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
4.95 | 18212800 18347146 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
4.95 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
7.91 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
7.91 | 17341418 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
7.91 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
26.04 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
26.04 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
26.04 | 18986760 16280240 17066447 16757204 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
imiquimod |
26.04 | 16302556 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
26.04 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
26.04 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
26.04 | 15984520 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
26.04 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
26.04 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
26.04 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
2.82 | 17572228 |
MESH:D006332 |
Cardiomegaly |
marker/mechanism |
|
| 10491406 |
MESH:D006332 |
Cardiomegaly |
|
cilnidipine |
8.40 | 16333380 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
8.40 | 17124262 16170337 15728586 11179087 11754973 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 18850075 16120746 18670907 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.05 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.33 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
8.33 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
8.33 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.49 | 17460283 |
MESH:D002418 |
Cattle Diseases |
|
Acrylamide |
4.54 | 12510666 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.03 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
14.03 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprost |
14.03 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.03 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.03 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.69 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.17 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
7.17 | 18291259 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.26 | 11181007 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.24 | 16461808 |
MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 17963255 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 17963255 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
7.09 | 12621046 8697196 16354765 15668235 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
7.09 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
7.09 | 12810352 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.09 | 17123785 |
MESH:D003092 |
Colitis |
|
resveratrol |
11.16 | 16474422 |
MESH:D003092 |
Colitis |
|
Thalidomide |
11.16 | 16680017 |
MESH:D003092 |
Colitis |
|
Tretinoin |
11.16 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
15.58 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
15.58 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
15.58 | 17287894 15001691 17725105 17169374 17016597 18772588 16510598 17172411 17018589 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
15.58 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
15.58 | 15637740 15936596 15625704 15786552 15963497 11260862 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
15.58 | 17725105 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
15.58 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
15.58 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.64 | 17016601 16331619 17094418 20501625 18288408 18802399 18949393 15148649 17594712 17401013 18448328 17454858 15289873 18509181 17255274 16303861 14970324 16282729 16391804 18383874 17695437 16524972 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
3.64 | 12606626 11197048 18059344 17054584 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
3.64 | 17454858 18259882 18509181 16391804 16303861 17159606 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.64 | 16550006 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
4.56 | 17323712 |
MESH:D003218 |
Condylomata Acuminata |
|
imiquimod |
6.22 | 16302556 11362904 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.28 | 14669216 17141729 |
MESH:D016510 |
Corneal Neovascularization |
marker/mechanism |
|
| 9301478 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
4.69 | 9301478 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.11 | 16507316 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
4.80 | 17302372 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
5.39 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
7.13 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
7.13 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.13 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
7.13 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
7.13 | 8800419 10589399 9125849 16925845 9224671 17551590 14991402 9664655 9142499 9211117 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
7.13 | 19769572 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
3.64 | 16078585 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.70 | 16002989 12952375 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.14 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.59 | 19747007 |
MESH:D003556 |
Cystitis |
|
Hydrochloric Acid |
4.56 | 20719367 12599022 12853844 19279288 |
MESH:D018856 |
Cystitis, Interstitial |
|
Hydrochloric Acid |
4.90 | 17714534 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
3.89 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.48 | 19031437 |
MESH:D003866 |
Depressive Disorder |
marker/mechanism |
|
| 16861106 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
6.95 | 12438553 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
6.95 | 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
6.95 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
3.81 | 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.02 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
10.02 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
10.02 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
10.02 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
10.02 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
10.02 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
10.53 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
10.53 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
10.53 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.61 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
5.49 | 7237001 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
5.49 | 7237001 7907874 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
4.64 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.75 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
12.75 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
12.75 | 16177239 11566570 16227642 3732212 7440962 7179309 21278145 2869522 19085960 15027814 10915739 10092053 15968718 19336974 9327722 6884620 7120509 4309450 15998439 6623471 17522070 3786805 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Drugs, Chinese Herbal |
12.75 | 15027814 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
12.75 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
scutellarin |
12.75 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.75 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.06 | 11462148 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.25 | 18446180 16133044 16326151 12774134 18043480 17190690 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
3.29 | 17151854 17202747 11535926 11595415 17329845 11595431 17045617 17351913 16699067 10671773 11991626 |
MESH:D004387 |
Dupuytren Contracture |
|
imiquimod |
5.87 | 16368197 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.49 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
12.17 | 20016425 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
12.17 | 16487989 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
12.17 | 16935035 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.03 | 17881519 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
10.04 | 9068938 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
10.04 | 9068938 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.60 | 12438553 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
20.42 | 8273558 |
MESH:D004487 |
Edema |
|
Dexamethasone |
20.42 | 19703484 |
MESH:D004487 |
Edema |
|
Furosemide |
20.42 | 11834646 |
MESH:D004487 |
Edema |
|
Indomethacin |
20.42 | 19703484 8273558 8985016 7990266 10653021 7907874 16100529 |
MESH:D004487 |
Edema |
|
resveratrol |
20.42 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
20.42 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
20.42 | 11698051 8273558 16716910 8113982 15177302 7812673 9599246 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
8.92 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
8.92 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
10.52 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
10.52 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.52 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
8.92 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
8.92 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
16.43 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.43 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.43 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.43 | 20544844 16202921 17893378 19155303 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.43 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
10.70 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
10.70 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
10.70 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
3.61 | 18509659 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
3.84 | 10567023 17763956 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
9.46 | 17980183 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
9.46 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.20 | 11298111 |
MESH:D004935 |
Esophageal Diseases |
|
Hydrochloric Acid |
4.90 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
5.30 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
5.30 | 15173087 16337965 17638652 16785472 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
5.30 | 11005569 |
MESH:D004941 |
Esophagitis |
|
Hydrochloric Acid |
5.10 | 12928072 |
MESH:D004942 |
Esophagitis, Peptic |
|
Hydrochloric Acid |
5.10 | 11346197 14621274 20516732 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.45 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.45 | 9664655 16938888 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
4.70 | 19890266 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
8.57 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
8.57 | 12631006 61145 15959796 19224547 12795759 16239168 17595544 16045604 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.57 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.12 | 16534752 16611131 16002989 16513791 15751030 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.12 | 16709447 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
4.93 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.58 | 11858732 |
MESH:D005334 |
Fever |
|
Dinoprost |
7.27 | 11852909 |
MESH:D005334 |
Fever |
|
Indomethacin |
7.27 | 10431976 11852909 17627676 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.63 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.29 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
4.00 | 10962813 |
MESH:D005355 |
Fibrosis |
|
arsenite |
23.36 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
23.36 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Hydrochloric Acid |
23.36 | 18497604 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
23.36 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
23.36 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
23.36 | 17994277 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.26 | 11298111 |
MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
4.90 | 19093184 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
9.10 | 20016425 |
MESH:D005739 |
Gas Poisoning |
|
Hydrochloric Acid |
9.10 | 12378975 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
3.84 | 15046732 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Hydrochloric Acid |
4.47 | 20516732 19957777 20545468 20616304 19951613 12212954 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
9.84 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
9.84 | 16452187 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
5.39 | 12701121 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
11.70 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
11.70 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
temozolomide |
11.70 | 15865885 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.70 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
10.39 | 16145905 |
MESH:D005910 |
Glioma |
|
Indomethacin |
10.39 | 16487511 18371953 |
MESH:D005910 |
Glioma |
|
temozolomide |
10.39 | 10871815 16327979 |
MESH:D005910 |
Glioma |
|
Thalidomide |
10.39 | 16327979 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.54 | 11849393 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.68 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.45 | 11248219 |
MESH:D017789 |
Granuloma, Pyogenic |
|
imiquimod |
6.22 | 16302556 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
13.05 | 15162350 15102660 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
13.05 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
13.05 | 15984520 18607998 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
13.05 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.05 | 17868369 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.24 | 16084493 |
MESH:D006356 |
Heartburn |
|
Hydrochloric Acid |
4.90 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
18.96 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
18.96 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
18.96 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
18.96 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
18.96 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
18.96 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
3.57 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Dobutamine |
5.93 | 17440445 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
5.93 | 12660669 16011733 16845234 |
MESH:D006391 |
Hemangioma |
|
imiquimod |
5.87 | 16302556 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.52 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
3.75 | 15633222 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
11.03 | 19900420 19110552 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
11.03 | 16487989 |
MESH:D006505 |
Hepatitis |
|
Drugs, Chinese Herbal |
11.03 | 18339527 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
3.82 | 15135802 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.04 | 16120746 12621046 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
marker/mechanism |
|
| 10646786 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
10.16 | 16863852 16490937 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
10.16 | 7520565 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
10.16 | 11588001 9575882 12547725 11685700 16473863 17270546 16080930 10370017 10541330 15707848 16292651 11076806 9473106 15793718 9476886 10898222 18280291 17245593 17618886 10646786 12746050 12505043 7576705 18280292 16863852 8863223 15764645 18958481 11051153 10370016 10359170 10898224 11409163 7520565 15136996 11584395 12407540 15185205 12021965 11057544 12194112 12904592 15088113 11329586 15578192 16720372 7760232 15756563 16490937 9859898 9698600 10693666 12759764 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
10.16 | 16490937 16863852 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.12 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
11.68 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
phosphomannopentaose sulfate |
11.68 | 16366604 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
11.68 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.28 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
5.12 | 16135485 17606976 15147373 16200630 18180244 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
5.12 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
7.04 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
7.04 | 14716179 |
MESH:D018327 |
Hutchinson's Melanotic Freckle |
|
imiquimod |
6.22 | 16302556 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.13 | 16959395 8697196 16354765 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
9.01 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
9.01 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
9.01 | 16769263 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
4.80 | 17883296 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.63 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
8.58 | 17652376 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
8.58 | 19622757 18089816 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
4.75 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.20 | 17188708 |
MESH:D006940 |
Hyperemia |
|
Hydrochloric Acid |
9.76 | 12646421 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
9.76 | 12524144 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.69 | 16778211 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
8.83 | 1977408 14960337 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
8.83 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
6.73 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
6.73 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
4.96 | 15086907 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.56 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.74 | 17042910 |
MESH:D006973 |
Hypertension |
|
Nifedipine |
8.74 | 20102058 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.74 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.74 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
8.50 | 15338365 |
MESH:D006975 |
Hypertension, Portal |
|
Hydrochloric Acid |
8.50 | 16984587 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
4.41 | 16612254 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Hydrochloric Acid |
3.77 | 19262391 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
3.73 | 12791704 18502941 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.50 | 17488730 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.28 | 12669777 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
4.75 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
4.96 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
3.70 | 16002989 |
MESH:D007022 |
Hypotension |
|
Furosemide |
7.04 | 11041285 |
MESH:D007022 |
Hypotension |
|
Hydrochloric Acid |
7.04 | 11574821 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
4.51 | 15811171 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.11 | 10574470 18306037 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.45 | 16133968 10651667 10647630 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.46 | 16133044 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
8.58 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
8.58 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.50 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Acrylamide |
8.16 | 11020651 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
8.16 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
Acrylamide |
14.21 | 12507653 15749267 11020651 15355880 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
14.21 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
14.21 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Gossypol |
14.21 | 11202417 9639145 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
14.21 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
32.46 | 8273558 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
32.46 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Hydrochloric Acid |
32.46 | 11574821 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
32.46 | 12568917 3291741 7812673 |
MESH:D007249 |
Inflammation |
|
Nickel |
32.46 | 16166738 |
MESH:D007249 |
Inflammation |
|
polyphenols |
32.46 | 16366677 |
MESH:D007249 |
Inflammation |
|
Progesterone |
32.46 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
32.46 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
32.46 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
32.46 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
32.46 | 15177302 7812673 7562506 8273558 11698051 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
32.46 | 16134734 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
8.07 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
8.07 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.33 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Hydrochloric Acid |
11.56 | 11574821 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
11.56 | 11713966 10210152 15831440 17994277 17329856 11686837 18236018 15610444 11855677 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
11.56 | 17994277 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
4.46 | 15241188 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.21 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.21 | 17551590 15992940 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.11 | 16133968 10574470 18306037 |
MESH:D007642 |
Keratosis |
|
imiquimod |
5.67 | 16302556 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
16.12 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
16.12 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
16.12 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
16.12 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
16.12 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
16.12 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
3.46 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
15.40 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
15.40 | 14681315 15003126 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
15.40 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
15.40 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
15.40 | 18625569 |
MESH:D007818 |
Laryngeal Diseases |
|
Hydrochloric Acid |
5.45 | 16498863 |
MESH:D007826 |
Laryngismus |
|
Hydrochloric Acid |
5.45 | 11510729 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.20 | 17184923 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.16 | 11703811 12228301 10320625 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
3.63 | 16514283 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
10.59 | 12970779 |
MESH:D007938 |
Leukemia |
|
Genistein |
10.59 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
temozolomide |
10.59 | 17500047 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
10.59 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Drugs, Chinese Herbal |
3.46 | 15802533 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
3.95 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
14.66 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
14.66 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
14.66 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
3.22 | 15631656 10785260 16572323 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
2.89 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
4.75 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
4.75 | 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.75 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
5.59 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
5.59 | 19642359 17506722 16788101 19075265 17712046 17361223 9834237 12679006 16891316 16331271 17294898 19029980 16823087 17368321 17649720 19225113 19035177 15748426 17301526 16766008 17107899 16140955 16935935 17339181 17217047 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.46 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
4.80 | 17980183 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
6.23 | 10473037 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.23 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
5.77 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
5.77 | 17567588 15342952 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
4.80 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
therapeutic |
|
| 17093919 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
14.61 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
14.61 | 11903743 16943688 17334410 11408273 16239168 16221502 17174718 21278145 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Drugs, Chinese Herbal |
14.61 | 17163593 |
MESH:D008103 |
Liver Cirrhosis |
|
Hydrochloric Acid |
14.61 | 16984587 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
14.61 | 16943688 17174718 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
marker/mechanism |
|
| 16116963 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
22.97 | 14748882 16011737 16015684 15362042 17805973 15650968 12666154 17976157 17823541 15893842 16116963 16033810 15370692 18205269 17761835 13678700 18277467 17900296 18317297 16097048 14512876 12586293 12389079 11481614 14716496 20821823 12898905 15123356 16136751 17721639 15338365 14724832 15730626 10355542 18481824 15996030 18210741 18429990 12632514 15052691 17708605 18279442 12649538 16027843 15925388 17565644 18054572 15959796 17922224 14716833 15931870 18263696 18395914 12609069 15673190 18395095 18006644 18420326 17944888 18339082 16638106 12741479 18472332 18376398 18166357 12958196 15057751 18187930 15818738 17714472 17698563 17631135 18472094 18418968 17481882 17766677 14620537 12632512 12546737 16192424 17557913 17525996 12445418 18251166 18705752 17640975 16248980 15876570 17869086 18156304 18412020 12445421 12667390 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
22.97 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Drugs, Chinese Herbal |
22.97 | 18371158 15763062 18606216 15849816 15383259 15818738 18567088 17881167 12632512 17348192 16610055 15864749 17629604 18237412 15754396 15339415 15744066 15641146 17036385 17666798 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
22.97 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
22.97 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
22.97 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Heparin |
22.97 | 16904936 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
22.97 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
silybin |
22.97 | 16169303 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
22.97 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
22.97 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
22.97 | 15465738 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
22.97 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
22.97 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.64 | 16964402 15720792 15830285 17285989 16246199 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
6.64 | 15991261 |
MESH:D008107 |
Liver Diseases |
|
Drugs, Chinese Herbal |
6.64 | 17207593 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
6.64 | 16698588 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.29 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
2.89 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
31.10 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
31.10 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
31.10 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
31.10 | 8742319 9539021 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
31.10 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Drugs, Chinese Herbal |
31.10 | 18339527 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
31.10 | 17045692 18383874 15113037 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
31.10 | 19812893 20405173 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
31.10 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
31.10 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
31.10 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
31.10 | 17093202 17559639 16391232 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
8.98 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
8.98 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
8.98 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.98 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Dobutamine |
4.02 | 19353679 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
29.04 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
29.04 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Dobutamine |
29.04 | 16638327 |
MESH:D008171 |
Lung Diseases |
|
Hydrochloric Acid |
29.04 | 16784557 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
29.04 | 9859898 17245593 16863852 9614859 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
29.04 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
29.04 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
29.04 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
10.34 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Hydrochloric Acid |
10.34 | 21114838 21311175 19644408 19262391 17627322 15044056 20597076 18573544 15607125 16129981 11395602 18339021 15090967 18497604 |
MESH:D055370 |
Lung Injury |
|
Ozone |
10.34 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
27.62 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
27.62 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
27.62 | 6695378 20464547 18520028 18569708 20135361 20064080 17053015 18816296 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
27.62 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Drugs, Chinese Herbal |
27.62 | 18339527 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
27.62 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
27.62 | 16537180 11497255 11053908 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
27.62 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
silybin |
27.62 | 16788158 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
27.62 | 16712894 17077188 17306315 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
27.62 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
27.62 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
27.62 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
27.62 | 16391232 16007126 11544531 11246140 12957351 16788158 11497255 17195641 16204055 14587096 12765245 11552296 11992545 11307925 6695378 16337739 11807781 12117781 10822126 15136453 11074608 17093202 17255336 10530776 11893704 7750092 10997738 10779650 12466968 11323394 11062179 16926031 15902970 15166089 16289808 |
MESH:D008175 |
Lung Neoplasms |
|
vanadium pentoxide |
27.62 | 12376484 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
27.62 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
3.89 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.25 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
5.62 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
5.62 | 12854902 12556972 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.46 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.12 | 14749477 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.60 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
7.05 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
7.05 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Drugs, Chinese Herbal |
26.00 | 14758024 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
26.00 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
26.00 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
26.00 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
26.00 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
26.00 | 16827153 11731420 19196722 14580682 19196723 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
26.00 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
26.00 | 17927505 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
26.00 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
9.62 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
9.62 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.33 | 17453147 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
11.27 | 11746506 17992120 |
MESH:D008545 |
Melanoma |
|
resveratrol |
11.27 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
11.27 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
11.27 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
temozolomide |
11.27 | 12374674 15577323 17576461 16248763 18281670 16432458 16225601 10623706 16260693 12829675 17623835 16260697 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
11.27 | 16098027 12829675 17089043 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
11.27 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.29 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.55 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
3.10 | 16856516 |
MESH:D008654 |
Mesothelioma |
marker/mechanism |
|
| 15878867 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
7.78 | 16966607 16166281 18303189 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
7.78 | 15878867 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
7.78 | 16675582 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.56 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
3.65 | 19142101 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.19 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
3.00 | 11903285 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
10.21 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
10.21 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
10.21 | 12636206 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.11 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
11.72 | 15867202 16118317 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
11.72 | 17164350 16490592 16267019 14749477 17049120 17935668 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
11.72 | 15867202 15939924 15744524 17168659 19112201 15741222 19112817 19372569 16445831 15920492 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
11.72 | 18089719 16996129 19621390 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
9.65 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
9.65 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
9.02 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
9.02 | 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.02 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
6.90 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Hydrochloric Acid |
6.90 | 18534312 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
6.90 | 16525036 17015251 17188708 17125593 16317513 16456233 |
MESH:D017202 |
Myocardial Ischemia |
therapeutic |
|
| 12173832 14583313 |
MESH:D017202 |
Myocardial Ischemia |
|
Dobutamine |
11.13 | 12447174 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
11.13 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
11.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
6.09 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
6.09 | 17141266 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.86 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
2.97 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
12.95 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
12.95 | 11239499 11053908 16537180 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
12.95 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
12.95 | 19393235 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
12.95 | 19139120 15867366 17312309 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.13 | 19410462 |
MESH:D009369 |
Neoplasms |
|
4-phenylbutyric acid |
25.50 | 19116145 |
MESH:D009369 |
Neoplasms |
|
alliin |
25.50 | 16351512 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
25.50 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
25.50 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
25.50 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
25.50 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
25.50 | 16365874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
25.50 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
25.50 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Urethane |
25.50 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
14.72 | 10663608 15625704 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
14.72 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
14.72 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
14.72 | 15582191 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.09 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
alliin |
22.42 | 16351512 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
22.42 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
22.42 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
22.42 | 16365874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
parthenolide |
22.42 | 16921510 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
4.96 | 15086907 |
MESH:D009404 |
Nephrotic Syndrome |
marker/mechanism |
|
| 21441931 |
MESH:D009410 |
Nerve Degeneration |
|
Acrylamide |
3.97 | 12387367 11264303 12387366 |
MESH:D009422 |
Nervous System Diseases |
|
Acrylamide |
4.21 | 12507653 12164553 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
27.34 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
27.34 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
27.34 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
27.34 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
27.34 | 16859833 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
27.34 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
8.49 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
8.49 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
8.49 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
8.54 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
temozolomide |
8.54 | 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
8.54 | 15176712 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
9.99 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
9.99 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
9.99 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
3.84 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.56 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
6.08 | 15081274 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
6.08 | 16436463 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
4.96 | 17945291 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
4.09 | 17217161 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.09 | 19142110 18515891 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.26 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
6.73 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Hydrochloric Acid |
6.73 | 12378975 |
MESH:D009914 |
Oral Submucous Fibrosis |
marker/mechanism |
|
| 16311067 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
3.05 | 7009135 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
4.47 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
5.48 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
5.48 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Drugs, Chinese Herbal |
12.18 | 16548355 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
12.18 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
12.18 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
23.45 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
23.45 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
23.45 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
23.45 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
23.45 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
23.45 | 16288038 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
23.45 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
23.45 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
23.45 | 16391232 |
MESH:D010146 |
Pain |
|
Indomethacin |
7.18 | 3291741 17627676 13679232 17440234 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.18 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
7.18 | 16475674 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
3.77 | 12538197 18702446 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
8.78 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
8.78 | 16929163 16500647 15113037 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.78 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.78 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.11 | 15028970 17883296 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
6.73 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
6.73 | 8330346 18404319 12065085 18922899 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
4.80 | 16537180 |
MESH:D010291 |
Paresis |
|
Thalidomide |
5.39 | 9200351 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.12 | 11181820 11445065 17291500 16809432 16112328 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
3.33 | 12349958 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
4.80 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.33 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.25 | 11148446 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
4.00 | 17225004 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Acrylamide |
4.26 | 11510240 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.26 | 16369182 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.26 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
9.22 | 15687265 16977796 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
9.22 | 16391232 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.01 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.50 | 18381685 18929643 18007984 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Hydrochloric Acid |
4.48 | 18497604 18573544 15607125 15970105 |
MESH:D011041 |
Poisoning |
|
Diazinon |
3.54 | 17603234 |
MESH:D011141 |
Polyuria |
|
Furosemide |
4.75 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.70 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
6.00 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
6.00 | 17031469 |
MESH:D011225 |
Pre-Eclampsia |
|
Iloprost |
5.00 | 10329876 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.25 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
11.18 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
11.18 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.18 | 11222880 11118676 11896295 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.06 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
6.18 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
6.18 | 17136230 15046698 15846301 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
6.18 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
6.18 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
6.18 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
6.18 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
6.18 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
parthenolide |
6.18 | 16921510 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
6.18 | 17718901 17636462 16731767 17675339 15767336 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
6.18 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
6.18 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
6.18 | 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
6.18 | 12504091 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
6.18 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
6.18 | 12438248 19103299 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
6.57 | 11849393 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
6.57 | 16636307 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
5.39 | 12755975 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
3.49 | 15331141 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.89 | 16723453 |
MESH:D001261 |
Pulmonary Atelectasis |
|
Hydrochloric Acid |
5.10 | 20597076 |
MESH:D011654 |
Pulmonary Edema |
|
Hydrochloric Acid |
4.31 | 15090967 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.42 | 14606601 |
MESH:D011658 |
Pulmonary Fibrosis |
marker/mechanism |
|
| 8952537 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
4.69 | 17365031 17322281 17975199 15814490 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Drugs, Chinese Herbal |
4.69 | 16987627 |
MESH:D011928 |
Raynaud Disease |
|
Iloprost |
5.71 | 16363279 |
MESH:D012003 |
Rectal Fistula |
|
Drugs, Chinese Herbal |
5.05 | 15043669 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.23 | 15538739 16160472 18722050 18286688 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.67 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
marker/mechanism |
|
| 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
5.33 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.33 | 16314181 15827377 17520802 17058453 16317513 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.30 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
14.92 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
14.92 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
14.92 | 15912074 16096441 12394941 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Hydrochloric Acid |
14.92 | 17627322 18549715 16784557 16129981 18339021 |
MESH:D012133 |
Respiratory Paralysis |
|
Hydrochloric Acid |
5.45 | 11510729 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
3.77 | 16611668 17119214 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
8.12 | 17119214 16611668 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Hydrochloric Acid |
8.12 | 20516732 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
2.97 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.26 | 16283617 16116481 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Drugs, Chinese Herbal |
4.37 | 15015336 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.44 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
7.97 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
7.97 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
imiquimod |
5.53 | 16302556 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.58 | 20452607 20168265 11763009 16141801 20521326 17667964 20580759 18806925 18855531 19369910 17726453 20521320 20107430 17123785 11151749 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.04 | 16096327 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.39 | 18551238 |
MESH:D012640 |
Seizures |
|
Kainic Acid |
6.39 | 14637104 18657176 1641125 17827730 15686955 10686065 16336964 19186208 19414003 |
MESH:D012640 |
Seizures |
|
Nicotine |
6.39 | 17873105 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
5.17 | 6418539 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
3.81 | 7327846 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Heparin |
5.18 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
6.19 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonic acid |
6.19 | 21378128 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
6.19 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
22.81 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
22.81 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
22.81 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
22.81 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
22.81 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
22.81 | 8330346 12065085 18404319 11807781 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
22.81 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
22.81 | 11807781 |
MESH:D012893 |
Sleep Disorders |
|
Kainic Acid |
4.81 | 19414003 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
8.82 | 16709447 16002989 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
8.82 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
7.91 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
7.91 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.06 | 12854658 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.51 | 1977408 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
7.41 | 15472012 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
7.41 | 16113693 15038085 10192188 10215738 18545984 10486359 16280098 15472012 16184426 17207306 17638125 17160473 18209964 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
9.59 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Drugs, Chinese Herbal |
9.59 | 18339527 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
9.59 | 17498489 17522103 18567086 18396642 16951190 16424979 19084572 17172411 19015929 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
9.59 | 17052386 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
9.59 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
9.59 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
9.59 | 18553229 16557585 18506536 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
9.59 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
25.69 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Aluminum Silicates |
25.69 | 16335828 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
25.69 | 18726076 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
25.69 | 15138204 |
MESH:D013276 |
Stomach Ulcer |
|
Hydrochloric Acid |
25.69 | 16755016 15309881 17189318 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
25.69 | 12498302 18726076 18209962 17895592 18299717 17918041 11729361 18181030 16252198 12787963 11595415 17654042 18087811 16397915 17657623 11906479 11595431 16150113 12500499 15255614 16169175 17977527 16934674 1323529 18193104 17627676 12467913 10878458 11145282 16631530 14567935 18237397 10423059 17135157 16755016 18431645 11523592 15104355 10750652 15138204 12077510 18543354 |
MESH:D013276 |
Stomach Ulcer |
|
Nifedipine |
25.69 | 14653237 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
25.69 | 15138204 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
6.41 | 16517955 16403987 |
MESH:D020521 |
Stroke |
|
Vitamin E |
6.41 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.68 | 16321402 |
MESH:D013345 |
Subarachnoid Hemorrhage |
|
Drugs, Chinese Herbal |
4.85 | 17634840 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.34 | 17997062 |
MESH:D013733 |
Testicular Diseases |
|
Acrylamide |
4.34 | 15864552 |
MESH:D013921 |
Thrombocytopenia |
|
Heparin |
4.66 | 16893407 16651880 |
MESH:D013927 |
Thrombosis |
|
Heparin |
4.53 | 16893407 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
2.99 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
5.02 | 14736730 18791128 11352223 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
5.02 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.77 | 19048282 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.02 | 16785264 11259349 16720336 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
4.57 | 17979512 18305452 15735609 18041664 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
11.97 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
11.97 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
11.97 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
Dobutamine |
4.46 | 19353679 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.60 | 16040207 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
4.00 | 17380554 10574470 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
13.84 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
13.84 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
13.84 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
13.84 | 17306315 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
13.84 | 17306315 11723127 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
13.84 | 16712894 17572228 8653321 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
4.37 | 16487989 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.42 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
21.26 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
21.26 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
21.26 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
21.26 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
21.26 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.26 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
6.95 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
6.95 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.70 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
3.91 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
8.68 | 16002989 16513791 |
MESH:D014625 |
Vaginal Neoplasms |
|
temozolomide |
8.68 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
9.15 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
9.15 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.68 | 12125929 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.00 | 10620525 |
MESH:D014657 |
Vasculitis |
|
Heparin |
5.18 | 20337814 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.43 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.20 | 16761959 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
3.84 | 11897121 |
MESH:D014860 |
Warts |
|
imiquimod |
5.88 | 16368197 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.33 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
3.69 | 20107430 16141801 20564506 16402076 20521320 17502770 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.18 | 17933447 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.18 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Drugs, Chinese Herbal |
3.79 | 16313111 |